ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
LOS ANGELES, March 08, 2023 (GLOBE NEWSWIRE) — ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce their plans to launch a new hair regrowth product using Minoxidil (topical route). The company will incorporate their proprietary, patent-pending dual carrier transdermal delivery technology with Minoxidil to create their new hair regrowth product.
Related news for (VDRM)
- ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance
- ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India
- ViaDerma Announces Significant 2024 Achievements and International Expansion
- ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
- ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product